Rose Geoffrey Beran: insider trades.
Rose Geoffrey Beran reported 4 non-derivative transactions on 1 SEC ownership filings in Q3 2026: 0 open-market purchases and 4 sales ($18K), across 1 company.
- Transactions
- 4
- Purchases (P)
- 0
- Sales (S)
- 4
- Companies
- 1
- Name as filed
- Rose Geoffrey Beran
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Pulmonx Corp (LUNG) | Officer · Chief Commercial Officer | 4 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-01 | Pulmonx Corp | S | 2,213 | $2.26 | 455,498 | Form 4 |
| 2026-09-01 | Pulmonx Corp | S | 1,530 | $2.26 | 451,578 | Form 4 |
| 2026-09-01 | Pulmonx Corp | S | 1,746 | $2.26 | 449,832 | Form 4 |
| 2026-09-01 | Pulmonx Corp | S | 2,390 | $2.26 | 453,108 | Form 4 |
Questions
What stock did Rose Geoffrey Beran buy or sell?
Rose Geoffrey Beran reported 4 non-derivative transactions on 1 SEC ownership filings in Q3 2026: 0 open-market purchases and 4 sales ($18K), across 1 company.
Is Rose Geoffrey Beran the same person as other filers with this name?
This page covers SEC CIK 1804146 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/rose-geoffrey-beran-1804146.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.